The global pet wheelchair market is valued at approximately USD 460.38 million in 2023 and is anticipated to grow with a healthy growth rate of more than 7.59% over the forecast period 2024-2032. The rising pet adoption rate, increasing awareness of pet health and mobility solutions, and advancements in veterinary care have significantly contributed to the market's growth. With growing concerns about pet mobility issues caused by age-related conditions, injuries, and genetic disorders, pet owners are increasingly opting for assistive devices such as wheelchairs to enhance their pets’ quality of life. Furthermore, the availability of pet insurance plans covering mobility aids has encouraged pet owners to invest in wheelchairs for their disabled or aging pets without financial constraints.
The pet wheelchair market is witnessing substantial demand, particularly for customized and adjustable wheelchairs, owing to advancements in materials like aluminum and carbon fiber. These materials provide lightweight and durable solutions, allowing pets to regain mobility efficiently. The use of 3D printing and AI-driven customization in pet wheelchairs further enhances comfort, ensuring a tailored fit for pets of all sizes. Additionally, e-commerce platforms such as Amazon, Chewy, and pet specialty online retailers have revolutionized accessibility, making pet mobility aids widely available to pet owners worldwide.
The increasing prevalence of arthritis, hip dysplasia, degenerative myelopathy, and spinal injuries in pets has propelled the adoption of wheelchairs as a standard mobility aid. According to a 2024 report by the Morris Animal Foundation, around 14 million adult dogs in the U.S. suffer from osteoarthritis, making it a leading cause of mobility challenges. Similarly, feline diabetes-related neuropathy has emerged as a growing concern, leading to an increased demand for cat wheelchairs. As a result, veterinary clinics and rehabilitation centers are recommending pet wheelchairs as part of post-surgical and therapeutic recovery programs.
Regionally, North America dominated the market in 2024, holding a 54.90% revenue share, driven by increased pet ownership, rising pet insurance penetration, and the presence of key manufacturers. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period, attributed to rising disposable incomes, growing pet humanization trends, and expanding veterinary care facilities in countries like China, Japan, and India. Meanwhile, in Europe, increasing pet humanization and the rising incidence of arthritis in companion animals are further fueling market expansion.
Major Market Players Included in This Report Are:
• Doggon Wheels
• Eddie's Wheels for Pets
• K9 Carts
• Pfaff Tierorthopädie
• Best Friend Mobility
• Walkin' Pets
• Mintbowl Inc.
• LaraCart Dog Wheelchairs
• Orthopets
• Animal Ortho Care
• HandicappedPets.com
• My Pet’s Brace
• Meister Werkstätten für Orthopädietechnik
• Bionic Pets
• Pawsitive Steps Rehab
The Detailed Segments and Sub-Segments of the Market Are Explained Below:
By Pet:
• Dogs
• Cats
• Others
By Product:
• Adjustable Wheelchairs
• Non-Adjustable Wheelchairs
By Material:
• Aluminum
• Others
By Distribution Channel:
• Others
• E-Commerce
By End-use:
• Veterinary Clinics
• Pet Rehabilitation Centers
• Pet Owners
By Region:
North America
• U.S.
• Canada
• Mexico
Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Rest of APAC
Latin America
• Brazil
• Argentina
• Rest of LATAM
Middle East & Africa (MEA)
• Saudi Arabia
• UAE
• South Africa
• Kuwait
• Rest of MEA
Years Considered for the Study Are as Follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032
• Annualized revenues and regional-level analysis for each market segment
• Detailed analysis of geographical landscape with country-level breakdown
• Competitive landscape with information on major players in the market
• Analysis of key business strategies and recommendations on future market approach
• Analysis of competitive structure of the market
• Demand-side and supply-side analysis of the market
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- Chapter 1. Global Pharmaceutical Quality Management Software Market Executive Summary
- 1.1. Global Pharmaceutical Quality Management Software Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Application
- 1.3.2. By Deployment Mode
- 1.4. Key Market Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
- Chapter 2. Global Pharmaceutical Quality Management Software Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Pharmaceutical Quality Management Software Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Increasing regulatory compliance requirements in the pharmaceutical industry
- 3.1.2. Growing adoption of cloud-based QMS solutions
- 3.1.3. Expansion of AI-powered QMS for pharmaceutical manufacturing
- 3.2. Market Challenges
- 3.2.1. High implementation costs of advanced quality management software
- 3.2.2. Data security concerns in cloud-based quality management
- 3.3. Market Opportunities
- 3.3.1. Integration of AI and blockchain in QMS solutions
- 3.3.2. Expansion of pharmaceutical R&D in emerging markets
- 3.3.3. Adoption of QMS in personalized medicine and biopharmaceuticals
- Chapter 4. Global Pharmaceutical Quality Management Software Market Industry Analysis
- 4.1. Porter’s Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Pharmaceutical Quality Management Software Market Size & Forecasts by Application (2022-2032)
- 5.1. Segment Dashboard
- 5.2. Global Pharmaceutical Quality Management Software Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Data Management
- 5.2.2. Risk Management
- 5.2.3. Audit Management
- 5.2.4. Compliance & Regulatory Management
- 5.2.5. Document Control & Training Management
- 5.2.6. CAPA Management
- 5.2.7. Supplier Quality Management
- 5.2.8. Others
- Chapter 6. Global Pharmaceutical Quality Management Software Market Size & Forecasts by Deployment Mode (2022-2032)
- 6.1. Segment Dashboard
- 6.2. Global Pharmaceutical Quality Management Software Market: Deployment Mode Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Cloud & Web-based
- 6.2.2. On-premise
- Chapter 7. Global Pharmaceutical Quality Management Software Market Size & Forecasts by Region (2022-2032)
- 7.1. North America
- 7.1.1. U.S.
- 7.1.2. Canada
- 7.1.3. Mexico
- 7.2. Europe
- 7.2.1. UK
- 7.2.2. Germany
- 7.2.3. France
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. Denmark
- 7.2.7. Sweden
- 7.2.8. Norway
- 7.3. Asia Pacific
- 7.3.1. China
- 7.3.2. Japan
- 7.3.3. India
- 7.3.4. South Korea
- 7.3.5. Australia
- 7.3.6. Thailand
- 7.4. Latin America
- 7.4.1. Brazil
- 7.4.2. Argentina
- 7.5. Middle East & Africa
- 7.5.1. South Africa
- 7.5.2. Saudi Arabia
- 7.5.3. UAE
- 7.5.4. Kuwait
- Chapter 8. Competitive Intelligence
- 8.1. Key Company SWOT Analysis
- 8.1.1. MasterControl Solutions, Inc.
- 8.1.2. Qualio
- 8.1.3. Veeva Systems
- 8.2. Top Market Strategies
- 8.3. Company Profiles
- 8.3.1. MasterControl Solutions, Inc.
- 8.3.2. AmpleLogic
- 8.3.3. Qualio
- 8.3.4. Pilgrim (IQVIA)
- 8.3.5. QT9
- 8.3.6. Sparta Systems (TrackWise)
- 8.3.7. AssurX, Inc.
- 8.3.8. Dassault Systèmes
- 8.3.9. ETQ, LLC (Hexagon)
- 8.3.10. Veeva Systems
- 8.3.11. Qualityze Inc.
- 8.3.12. Ideagen
- Chapter 9. Research Process
- 9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
- 9.2. Research Attributes
- List of Tables
- TABLE 1. Global Pharmaceutical Quality Management Software Market, Report Scope
- TABLE 2. Market Estimates & Forecasts by Region, 2022-2032 (USD Million/Billion)
- TABLE 3. Market Estimates & Forecasts by Application, 2022-2032 (USD Million/Billion)
- TABLE 4. Market Estimates & Forecasts by Deployment Mode, 2022-2032 (USD Million/Billion)
- TABLE 5. North America Market Breakdown, 2022-2032
- TABLE 6. Europe Market Breakdown, 2022-2032
- TABLE 7. Asia Pacific Market Breakdown, 2022-2032
- List of Figures
- FIGURE 1. Global Pharmaceutical Quality Management Software Market Research Methodology
- FIGURE 2. Market Estimation Techniques
- FIGURE 3. Global Market Size & Forecast, 2022-2032
- FIGURE 4. Regional Market Analysis, 2022-2032
- FIGURE 5. Porter’s Five Forces Model
- FIGURE 6. Competitive Landscape Analysis
- This list is not complete; the final report contains more than 50 figures.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook